Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2003 Jul;62(7):597–604. doi: 10.1136/ard.62.7.597

Interpreting radiographic data in rheumatoid arthritis

P Ory
PMCID: PMC1754596  PMID: 12810418

Full Text

The Full Text of this article is available as a PDF (149.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bathon J. M., Martin R. W., Fleischmann R. M., Tesser J. R., Schiff M. H., Keystone E. C., Genovese M. C., Wasko M. C., Moreland L. W., Weaver A. L. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med. 2000 Nov 30;343(22):1586–1593. doi: 10.1056/NEJM200011303432201. [DOI] [PubMed] [Google Scholar]
  2. Boers M. The validity of radiography as outcome measure in rheumatoid arthritis. J Rheumatol. 1995 Sep;22(9):1783–1786. [PubMed] [Google Scholar]
  3. Boers M., Tugwell P., Felson D. T., van Riel P. L., Kirwan J. R., Edmonds J. P., Smolen J. S., Khaltaev N., Muirden K. D. World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials. J Rheumatol Suppl. 1994 Sep;41:86–89. [PubMed] [Google Scholar]
  4. Boers M., Verhoeven A. C., Markusse H. M., van de Laar M. A., Westhovens R., van Denderen J. C., van Zeben D., Dijkmans B. A., Peeters A. J., Jacobs P. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet. 1997 Aug 2;350(9074):309–318. doi: 10.1016/S0140-6736(97)01300-7. [DOI] [PubMed] [Google Scholar]
  5. Boini S., Guillemin F. Radiographic scoring methods as outcome measures in rheumatoid arthritis: properties and advantages. Ann Rheum Dis. 2001 Sep;60(9):817–827. [PMC free article] [PubMed] [Google Scholar]
  6. Brennan P., Harrison B., Barrett E., Chakravarty K., Scott D., Silman A., Symmons D. A simple algorithm to predict the development of radiological erosions in patients with early rheumatoid arthritis: prospective cohort study. BMJ. 1996 Aug 24;313(7055):471–476. doi: 10.1136/bmj.313.7055.471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bresnihan B., Alvaro-Gracia J. M., Cobby M., Doherty M., Domljan Z., Emery P., Nuki G., Pavelka K., Rau R., Rozman B. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum. 1998 Dec;41(12):2196–2204. doi: 10.1002/1529-0131(199812)41:12<2196::AID-ART15>3.0.CO;2-2. [DOI] [PubMed] [Google Scholar]
  8. Brook A., Corbett M. Radiographic changes in early rheumatoid disease. Ann Rheum Dis. 1977 Feb;36(1):71–73. doi: 10.1136/ard.36.1.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Brower A. C. Radiographic assessment of disease progression in rheumatoid arthritis. Rheum Dis Clin North Am. 1991 Aug;17(3):471–485. [PubMed] [Google Scholar]
  10. Brown J. H., Deluca S. A. The radiology of rheumatoid arthritis. Am Fam Physician. 1995 Oct;52(5):1372–1380. [PubMed] [Google Scholar]
  11. Bruynesteyn K., van der Heijde D., Boers M., Lassere M., Boonen A., Edmonds J., Houben H., Paulus H., Peloso P., Saudan A. Minimal clinically important difference in radiological progression of joint damage over 1 year in rheumatoid arthritis: preliminary results of a validation study with clinical experts. J Rheumatol. 2001 Apr;28(4):904–910. [PubMed] [Google Scholar]
  12. Bruynesteyn Karin, van der Heijde Désirée, Boers Maarten, Saudan Ariane, Peloso Paul, Paulus Harold, Houben Harry, Griffiths Bridget, Edmonds John, Bresnihan Barry. Determination of the minimal clinically important difference in rheumatoid arthritis joint damage of the Sharp/van der Heijde and Larsen/Scott scoring methods by clinical experts and comparison with the smallest detectable difference. Arthritis Rheum. 2002 Apr;46(4):913–920. doi: 10.1002/art.10190. [DOI] [PubMed] [Google Scholar]
  13. Buckland-Wright J. C. X-ray assessment of activity in rheumatoid disease. Br J Rheumatol. 1983 Feb;22(1):3–10. doi: 10.1093/rheumatology/22.1.3. [DOI] [PubMed] [Google Scholar]
  14. Cuchacovich M., Couret M., Peray P., Gatica H., Sany J. Precision of the Larsen and the Sharp methods of assessing radiologic change in patients with rheumatoid arthritis. Arthritis Rheum. 1992 Jul;35(7):736–739. doi: 10.1002/art.1780350703. [DOI] [PubMed] [Google Scholar]
  15. Edmonds J., Saudan A., Lassere M., Scott D. Introduction to reading radiographs by the Scott modification of the Larsen method. J Rheumatol. 1999 Mar;26(3):740–742. [PubMed] [Google Scholar]
  16. Egsmose C., Lund B., Borg G., Pettersson H., Berg E., Brodin U., Trang L. Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study. J Rheumatol. 1995 Dec;22(12):2208–2213. [PubMed] [Google Scholar]
  17. Emery P., Breedveld F. C., Lemmel E. M., Kaltwasser J. P., Dawes P. T., Gömör B., Van Den Bosch F., Nordström D., Bjorneboe O., Dahl R. A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis. Rheumatology (Oxford) 2000 Jun;39(6):655–665. doi: 10.1093/rheumatology/39.6.655. [DOI] [PubMed] [Google Scholar]
  18. Ferrara R., Priolo F., Cammisa M., Bacarini L., Cerase A., Pasero G., Ferraccioli G. F., Alberighi O. D., Antonellini A., Marubini E. Clinical trials in rheumatoid arthritis: methodological suggestions for assessing radiographs arising from the GRISAR Study. Gruppo Reumatologi Italiani Studio Artrite Reumatoide. Ann Rheum Dis. 1997 Oct;56(10):608–612. doi: 10.1136/ard.56.10.608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Fries J. F. Current treatment paradigms in rheumatoid arthritis. Rheumatology (Oxford) 2000 Jun;39 (Suppl 1):30–35. doi: 10.1093/oxfordjournals.rheumatology.a031492. [DOI] [PubMed] [Google Scholar]
  20. Fuchs H. A., Kaye J. J., Callahan L. F., Nance E. P., Pincus T. Evidence of significant radiographic damage in rheumatoid arthritis within the first 2 years of disease. J Rheumatol. 1989 May;16(5):585–591. [PubMed] [Google Scholar]
  21. Fuchs H. A., Pincus T. Radiographic damage in rheumatoid arthritis: description by nonlinear models. J Rheumatol. 1992 Nov;19(11):1655–1658. [PubMed] [Google Scholar]
  22. Genant H. K. Interleukin-1 receptor antagonist treatment of rheumatoid arthritis patients: radiologic progression and correlation of Genant/Sharp and Larsen scoring methods. Semin Arthritis Rheum. 2001 Apr;30(5 Suppl 2):26–32. doi: 10.1053/sarh.2001.23697. [DOI] [PubMed] [Google Scholar]
  23. Genant H. K., Jiang Y., Peterfy C., Lu Y., Redei J., Countryman P. J. Assessment of rheumatoid arthritis using a modified scoring method on digitized and original radiographs. Arthritis Rheum. 1998 Sep;41(9):1583–1590. doi: 10.1002/1529-0131(199809)41:9<1583::AID-ART8>3.0.CO;2-H. [DOI] [PubMed] [Google Scholar]
  24. Genovese Mark C., Bathon Joan M., Martin Richard W., Fleischmann Roy M., Tesser John R., Schiff Michael H., Keystone Edward C., Wasko Mary Chester, Moreland Larry W., Weaver Arthur L. Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes. Arthritis Rheum. 2002 Jun;46(6):1443–1450. doi: 10.1002/art.10308. [DOI] [PubMed] [Google Scholar]
  25. Giovagnoni A., Valeri G., Burroni E., Amici F. Rheumatoid arthritis: follow-up and response to treatment. Eur J Radiol. 1998 May;27 (Suppl 1):S25–S30. doi: 10.1016/s0720-048x(98)00039-4. [DOI] [PubMed] [Google Scholar]
  26. Harris E. D., Jr Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med. 1990 May 3;322(18):1277–1289. doi: 10.1056/NEJM199005033221805. [DOI] [PubMed] [Google Scholar]
  27. Hulsmans H. M., Jacobs J. W., van der Heijde D. M., van Albada-Kuipers G. A., Schenk Y., Bijlsma J. W. The course of radiologic damage during the first six years of rheumatoid arthritis. Arthritis Rheum. 2000 Sep;43(9):1927–1940. doi: 10.1002/1529-0131(200009)43:9<1927::AID-ANR3>3.0.CO;2-B. [DOI] [PubMed] [Google Scholar]
  28. Kaye J. J. Radiographic methods of assessment (scoring) of rheumatic disease. Rheum Dis Clin North Am. 1991 Aug;17(3):457–470. [PubMed] [Google Scholar]
  29. Larsen A., Dale K., Eek M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn (Stockh) 1977 Jul;18(4):481–491. doi: 10.1177/028418517701800415. [DOI] [PubMed] [Google Scholar]
  30. Lassere M. N., van der Heijde D., Johnson K. R., Boers M., Edmonds J. Reliability of measures of disease activity and disease damage in rheumatoid arthritis: implications for smallest detectable difference, minimal clinically important difference, and analysis of treatment effects in randomized controlled trials. J Rheumatol. 2001 Apr;28(4):892–903. [PubMed] [Google Scholar]
  31. Lassere M. N., van der Heijde D., Johnson K., Bruynesteyn K., Molenaar E., Boonen A., Verhoeven A., Emery P., Boers M. Robustness and generalizability of smallest detectable difference in radiological progression. J Rheumatol. 2001 Apr;28(4):911–913. [PubMed] [Google Scholar]
  32. Lassere M. Pooled metaanalysis of radiographic progression: comparison of Sharp and Larsen methods. J Rheumatol. 2000 Jan;27(1):269–276. [PubMed] [Google Scholar]
  33. Lindqvist E., Jonsson K., Saxne T., Eberhardt K. Course of radiographic damage over 10 years in a cohort with early rheumatoid arthritis. Ann Rheum Dis. 2003 Jul;62(7):611–616. doi: 10.1136/ard.62.7.611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Lipsky P. E., van der Heijde D. M., St Clair E. W., Furst D. E., Breedveld F. C., Kalden J. R., Smolen J. S., Weisman M., Emery P., Feldmann M. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med. 2000 Nov 30;343(22):1594–1602. doi: 10.1056/NEJM200011303432202. [DOI] [PubMed] [Google Scholar]
  35. Luong B. T., Chong B. S., Lowder D. M. Treatment options for rheumatoid arthritis: celecoxib, leflunomide, etanercept, and infliximab. Ann Pharmacother. 2000 Jun;34(6):743–760. doi: 10.1345/aph.19344. [DOI] [PubMed] [Google Scholar]
  36. McQueen F. M., Stewart N., Crabbe J., Robinson E., Yeoman S., Tan P. L., McLean L. Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals a high prevalence of erosions at four months after symptom onset. Ann Rheum Dis. 1998 Jun;57(6):350–356. doi: 10.1136/ard.57.6.350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. McQueen F. M., Stewart N., Crabbe J., Robinson E., Yeoman S., Tan P. L., McLean L. Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals progression of erosions despite clinical improvement. Ann Rheum Dis. 1999 Mar;58(3):156–163. doi: 10.1136/ard.58.3.156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Mulherin D., Fitzgerald O., Bresnihan B. Clinical improvement and radiological deterioration in rheumatoid arthritis: evidence that the pathogenesis of synovial inflammation and articular erosion may differ. Br J Rheumatol. 1996 Dec;35(12):1263–1268. doi: 10.1093/rheumatology/35.12.1263. [DOI] [PubMed] [Google Scholar]
  39. Ostergaard M., Hansen M., Stoltenberg M., Gideon P., Klarlund M., Jensen K. E., Lorenzen I. Magnetic resonance imaging-determined synovial membrane volume as a marker of disease activity and a predictor of progressive joint destruction in the wrists of patients with rheumatoid arthritis. Arthritis Rheum. 1999 May;42(5):918–929. doi: 10.1002/1529-0131(199905)42:5<918::AID-ANR10>3.0.CO;2-2. [DOI] [PubMed] [Google Scholar]
  40. Pincus T., Callahan L. F., Fuchs H. A., Larsen A., Kaye J. Quantitative analysis of hand radiographs in rheumatoid arthritis: time course of radiographic changes, relation to joint examination measures, and comparison of different scoring methods. J Rheumatol. 1995 Oct;22(10):1983–1989. [PubMed] [Google Scholar]
  41. Plant M. J., Jones P. W., Saklatvala J., Ollier W. E., Dawes P. T. Patterns of radiological progression in early rheumatoid arthritis: results of an 8 year prospective study. J Rheumatol. 1998 Mar;25(3):417–426. [PubMed] [Google Scholar]
  42. Rau R., Wassenberg S., Herborn G., Perschel W. T., Freitag G. Identification of radiologic healing phenomena in patients with rheumatoid arthritis. J Rheumatol. 2001 Dec;28(12):2608–2615. [PubMed] [Google Scholar]
  43. Salaffi F., Carotti M. Interobserver variation in quantitative analysis of hand radiographs in rheumatoid arthritis: comparison of 3 different reading procedures. J Rheumatol. 1997 Oct;24(10):2055–2056. [PubMed] [Google Scholar]
  44. Scott D. L., Houssien D. A., Laasonen L. Proposed modification to Larsen's scoring methods for hand and wrist radiographs. Br J Rheumatol. 1995 Jan;34(1):56–56. doi: 10.1093/rheumatology/34.1.56. [DOI] [PubMed] [Google Scholar]
  45. Scott D. L., Laasonen L., Priolo F., Houssien D. A., Bacarini L., Cerase A., Cammisa M. The radiological assessment of rheumatoid arthritis. Clin Exp Rheumatol. 1997 May-Jun;15 (Suppl 17):S53–S61. [PubMed] [Google Scholar]
  46. Scott D. L., Pugner K., Kaarela K., Doyle D. V., Woolf A., Holmes J., Hieke K. The links between joint damage and disability in rheumatoid arthritis. Rheumatology (Oxford) 2000 Feb;39(2):122–132. doi: 10.1093/rheumatology/39.2.122. [DOI] [PubMed] [Google Scholar]
  47. Sharp J. T. Assessment of radiographic abnormalities in rheumatoid arthritis: what have we accomplished and where should we go from here? J Rheumatol. 1995 Sep;22(9):1787–1791. [PubMed] [Google Scholar]
  48. Sharp J. T., Lidsky M. D., Collins L. C., Moreland J. Methods of scoring the progression of radiologic changes in rheumatoid arthritis. Correlation of radiologic, clinical and laboratory abnormalities. Arthritis Rheum. 1971 Nov-Dec;14(6):706–720. doi: 10.1002/art.1780140605. [DOI] [PubMed] [Google Scholar]
  49. Sharp J. T. Scoring radiographic abnormalities in rheumatoid arthritis. Radiol Clin North Am. 1996 Mar;34(2):233-41, x. [PubMed] [Google Scholar]
  50. Sharp J. T., Strand V., Leung H., Hurley F., Loew-Friedrich I. Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group. Arthritis Rheum. 2000 Mar;43(3):495–505. doi: 10.1002/1529-0131(200003)43:3<495::AID-ANR4>3.0.CO;2-U. [DOI] [PubMed] [Google Scholar]
  51. Sharp J. T., Wolfe F., Mitchell D. M., Bloch D. A. The progression of erosion and joint space narrowing scores in rheumatoid arthritis during the first twenty-five years of disease. Arthritis Rheum. 1991 Jun;34(6):660–668. doi: 10.1002/art.1780340606. [DOI] [PubMed] [Google Scholar]
  52. Sharp J. T., Young D. Y., Bluhm G. B., Brook A., Brower A. C., Corbett M., Decker J. L., Genant H. K., Gofton J. P., Goodman N. How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis? Arthritis Rheum. 1985 Dec;28(12):1326–1335. doi: 10.1002/art.1780281203. [DOI] [PubMed] [Google Scholar]
  53. Simon L. S. DMARDs in the treatment of rheumatoid arthritis: current agents and future developments. Int J Clin Pract. 2000 May;54(4):243–249. [PubMed] [Google Scholar]
  54. Stenger A. A., Van Leeuwen M. A., Houtman P. M., Bruyn G. A., Speerstra F., Barendsen B. C., Velthuysen E., van Rijswijk M. H. Early effective suppression of inflammation in rheumatoid arthritis reduces radiographic progression. Br J Rheumatol. 1998 Nov;37(11):1157–1163. doi: 10.1093/rheumatology/37.11.1157. [DOI] [PubMed] [Google Scholar]
  55. Strand V., Cohen S., Schiff M., Weaver A., Fleischmann R., Cannon G., Fox R., Moreland L., Olsen N., Furst D. Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group. Arch Intern Med. 1999 Nov 22;159(21):2542–2550. doi: 10.1001/archinte.159.21.2542. [DOI] [PubMed] [Google Scholar]
  56. Watt I., Cobby M. Treatment of rheumatoid arthritis patients with interleukin-1 receptor antagonist: radiologic assessment. Semin Arthritis Rheum. 2001 Apr;30(5 Suppl 2):21–25. doi: 10.1053/sarh.2001.23691. [DOI] [PubMed] [Google Scholar]
  57. Weissman B. N. Imaging techniques in rheumatoid arthritis. J Rheumatol Suppl. 1994 Oct;42:14–19. [PubMed] [Google Scholar]
  58. Wolfe F., Lassere M., van der Heijde D., Stucki G., Suarez-Almazor M., Pincus T., Eberhardt K., Kvien T. K., Symmons D., Silman A. Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatology. J Rheumatol. 1999 Feb;26(2):484–489. [PubMed] [Google Scholar]
  59. Wolfe F., Sharp J. T. Radiographic outcome of recent-onset rheumatoid arthritis: a 19-year study of radiographic progression. Arthritis Rheum. 1998 Sep;41(9):1571–1582. doi: 10.1002/1529-0131(199809)41:9<1571::AID-ART7>3.0.CO;2-R. [DOI] [PubMed] [Google Scholar]
  60. van Der Heijde D., Boonen A., Boers M., Kostense P., van Der Linden S. Reading radiographs in chronological order, in pairs or as single films has important implications for the discriminative power of rheumatoid arthritis clinical trials. Rheumatology (Oxford) 1999 Dec;38(12):1213–1220. doi: 10.1093/rheumatology/38.12.1213. [DOI] [PubMed] [Google Scholar]
  61. van der Heijde D. M. Radiographic imaging: the 'gold standard' for assessment of disease progression in rheumatoid arthritis. Rheumatology (Oxford) 2000 Jun;39 (Suppl 1):9–16. doi: 10.1093/oxfordjournals.rheumatology.a031496. [DOI] [PubMed] [Google Scholar]
  62. van der Heijde D. M., van Leeuwen M. A., van Riel P. L., Koster A. M., van 't Hof M. A., van Rijswijk M. H., van de Putte L. B. Biannual radiographic assessments of hands and feet in a three-year prospective followup of patients with early rheumatoid arthritis. Arthritis Rheum. 1992 Jan;35(1):26–34. doi: 10.1002/art.1780350105. [DOI] [PubMed] [Google Scholar]
  63. van der Heijde D. M., van Riel P. L., Nuver-Zwart I. H., Gribnau F. W., vad de Putte L. B. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet. 1989 May 13;1(8646):1036–1038. doi: 10.1016/s0140-6736(89)92442-2. [DOI] [PubMed] [Google Scholar]
  64. van der Heijde D., Boers M., Lassere M. Methodological issues in radiographic scoring methods in rheumatoid arthritis. J Rheumatol. 1999 Mar;26(3):726–730. [PubMed] [Google Scholar]
  65. van der Heijde D. How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol. 2000 Jan;27(1):261–263. [PubMed] [Google Scholar]
  66. van der Heijde D. Radiographic progression in rheumatoid arthritis: does it reflect outcome? Does it reflect treatment? Ann Rheum Dis. 2001 Nov;60 (Suppl 3):iii47–iii50. doi: 10.1136/ard.60.90003.iii47. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. van der Heijde Désirée, Simon Lee, Smolen Josef, Strand Vibeke, Sharp John, Boers Maarten, Breedveld Ferdinand, Weisman Michael, Weinblatt Michael, Rau Rolf. How to report radiographic data in randomized clinical trials in rheumatoid arthritis: guidelines from a roundtable discussion. Arthritis Rheum. 2002 Apr 15;47(2):215–218. doi: 10.1002/art.10181. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES